An examination of factors influencing the choice of therapy for patients with coronary artery disease

Table 2 Demographics, angiogram scores, symptom reports and functional ability by treatment group

		Total	Medication	PTCA	CABG	p
		214	70	71	73
Gender	Male	175	52	57	66
	Female	39	18	14	7	0.041
Age	Mean	64.09	66.00	62.03	64.26	0.078
Education level	Mean	2.04	1. 97^a	2.51^b	1.64^a	<0.001
Angiogram scores	LAD artery disease	2.18	1.56^a	2.31^b	2.64^b	<0.001
	Circumflex artery disease	1.67	1.30^a	1.39^a	2.30^b	<0.001
	RCA disease	1.98	1.80	1.85	2.27	0.015
	Number of disease vessels	2.51	2.39^a	2.37^a	2.77^b	0.002
	Ventricular Function score	0.63	0.56^a	0.39^a	0.93^b	<0.001
Symptom frequency	Angina	2.03	1.80^a	2.18^b	2.11^b	0.005
	Dyspnoea	2.22	2.19	2.37	2.11	0.212
	Non-cardiac	1.43	1.38	1.46	1.46	0.196
Functional limitations	Angina associated	1.80	1.29^a	1.93^b	2.15^b	<0.001
	Dyspnoea associated	1.56	1.21	1.67	1.79	0.013
Activities of daily living	Social Behaviour	4.43	3.96^a	3.97^a	5.32^b	0.005
	Emotional Stability	1.30	1.43	1.48	1.00	0.112
	Mobility Range	1.91	1.00^a	1.15^a	3.52^b	<0.001
	Somatic Autonomy	0.84	0.94	0.58	0.99	0.200
	Mobility Control	4.00	3.81	3.63	4.53	0.143
	Psychological Autonomy & Communication	1.71	1.89	1.75	1.51	0.613

Gender analyses conducted with Chi-sq test, remainder with ANOVAs.
Significant treatment group differences revealed within the ANOVAs are indicated with different superscript letters.